Sort   by:  
 Page size 
UnknownRisk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Not available
S-EPMC5624832 | biostudies-literature
UnknownEstablishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Not available
S-EPMC5719923 | biostudies-literature
UnknownRisk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
Not available
S-EPMC5850026 | biostudies-literature
UnknownHIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
Not available
S-EPMC5513170 | biostudies-literature
UnknownLessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.
Not available
S-EPMC11840073 | biostudies-literature
UnknownApplication of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Not available
S-EPMC7217941 | biostudies-literature
UnknownViral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
Not available
S-EPMC2745911 | biostudies-literature
UnknownThe tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Not available
S-EPMC8636568 | biostudies-literature
UnknownDevelopment and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Not available
S-EPMC4380415 | biostudies-literature
UnknownPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Not available
S-EPMC7217863 | biostudies-literature
Sort   by:  
 Page size